Stay updated on Dupilumab Efficacy in CRSsNP: Clinical Trial
Sign up to get notified when there's something new on the Dupilumab Efficacy in CRSsNP: Clinical Trial page.

Latest updates to the Dupilumab Efficacy in CRSsNP: Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page displays the existing Dupilumab in CRSsNP study record, including its trial details, eligibility criteria, outcomes, and results links.SummaryDifference77%

- Check8 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check15 days agoChange DetectedA sitewide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check22 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2 while the page remains a 403 error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content and navigation. This indicates the record is currently inaccessible due to access restrictions.SummaryDifference18%

Stay in the know with updates to Dupilumab Efficacy in CRSsNP: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab Efficacy in CRSsNP: Clinical Trial page.